:: ::
Back to the articles list Back to browse issues page
The current status of bacillus Calmette‐Guérin vaccine protective efficacy
Patricia Méndez-Samperio *
Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional
Abstract:   (51 Views)
The bacillus Calmette‐Guérin (BCG) vaccine against pulmonary tuberculosis (TB) remains with poor protective efficacy. However BCG is the only licensed vaccine against human TB. This review discusses the main research progress in the field of TB vaccine development and will summarize the current status, and main challenges for the development of a safer and more efficient TB vaccine.
Keywords: |BCG|global health|clinical trials|tuberculosis|vaccine ,
Full-Text [PDF 429 kb]   (20 Downloads)    
Type of Study: Review article | Subject: Vaccine development, efficacy and safety evaluation
Received: 2020/01/16 | Accepted: 2020/03/11


XML     Print



Back to the articles list Back to browse issues page